Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-09-23

Clinical Trial Update: Study Evaluating Potential Drug Interaction Of Bazedoxifene & Premarin In Healthy Postmenopausal Women [Phase 1]

View source ↗

Summary

Phase 1 trial update on potential drug interaction between bazedoxifene and Premarin (conjugated estrogens) in healthy postmenopausal women; the study status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bazedoxifene (bazedoxifene)
  • PREMARIN (Conjugated estrogens)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Postmenopause | Phase 1 | Status: COMPLETED